{"id":753127,"date":"2023-05-01T11:10:11","date_gmt":"2023-05-01T15:10:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\/"},"modified":"2023-05-01T11:10:11","modified_gmt":"2023-05-01T15:10:11","slug":"fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\/","title":{"rendered":"Fulcrum Therapeutics, Inc. (FULC) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors &#8211; Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ATLANTA, May  01, 2023  (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC informs investors that it has filed a class action lawsuit against Fulcrum Therapeutics, Inc. (\u201cFulcrum\u201d\u202for the \u201cCompany\u201d) (NASDAQ: FULC). The lawsuit alleges Fulcrum made materially false and\/or misleading statements and\/or failed to disclose material adverse facts about the Company\u2019s business, operations, and compliance policies, including: (i) the preclinical data submitted in support of the Company\u2019s drug candidate, FTX-6058, showed safety concerns regarding potential hematological malignancies; (ii) the foregoing safety concerns increased the likelihood that the FDA would place a clinical hold on preclinical studies of FTX-6058; and (iii) accordingly, the Company had overstated FTX-6058\u2019s clinical and\/or commercial prospects.<\/p>\n<p align=\"justify\">If you bought shares of Fulcrum between March 3, 2022 and March 8, 2023, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EXhAZhUr_xEnPj1L47Qob1iX_MW35H6adq1NwkMybWGERnf6ZdlVgpVs9cNyCUV5pE63hhP_f37lXilCMFFd313DO5kFk-0B34N8o8zWntI=\" rel=\"nofollow noopener\" target=\"_blank\">cholzer@holzerlaw.com<\/a> or Joshua Karr, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DVRAYe6WgViq0UKz3T35cCZYdHDNxg21oLDATxVjNvIx5VGxHi8CfXc9Huq57csYjdTF3TsHoh286ztgT2FZVmJFo2kZgooNK4tmsGPYNRM=\" rel=\"nofollow noopener\" target=\"_blank\">jkarr@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832 or you may visit the firm\u2019s website\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3jCsGY-ZrOEj66m_vcXz9dndGl4-ub55CvOoROa9UdQ7k5RaOj8nWpAruldydiGFAnwwj_x29VGu3wzKfUOXQJTjmOG-p_zMrhyul9pFku-0ll9MI8Bx3VY6ebbyDDwI\" rel=\"nofollow noopener\" target=\"_blank\"><u>https:\/\/holzerlaw.com\/case\/fulcrum\/<\/u><\/a> to learn more.<\/p>\n<p align=\"justify\">\n        <strong>The deadline to ask the court to be appointed lead plaintiff in the case is June 27, 2023. <\/strong>\n      <\/p>\n<p align=\"justify\">Holzer &amp; Holzer, LLC, an ISS top rated securities litigation law firm for 2021 and 2022, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer &amp; Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct.\u202fMore information about the firm is available through its website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zowxR6P-Mg-aG8Agec8FT4CTSxRrdXwRj6fpinNifqiN4g9Yo4sa4fmI76VVurDezr2FlGeb68xRgvTQ2s88dA==\" rel=\"nofollow noopener\" target=\"_blank\">www.holzerlaw.com<\/a>, and upon request from the firm. Holzer &amp; Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.\u202f\u00a0<\/p>\n<p align=\"justify\">CONTACT:<br \/>Corey Holzer, Esq.<br \/>(888) 508-6832 (toll-free) <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EXhAZhUr_xEnPj1L47Qob1iX_MW35H6adq1NwkMybWG__b3UIDRhCFxoujIO1XEO8EiaIv25vLLBl73ZtQ5S7DZ7NFIiBV8lrBgcAoTQVYc=\" rel=\"nofollow noopener\" target=\"_blank\">cholzer@holzerlaw.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTA4NyM1NTY3MTk5IzIxODA3Njc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NmIzY2IwYTMtN2Q3OS00NjNkLTk3NzMtMjU2ZjcxMDU5OWY2LTExOTIzMzY=\/tiny\/Holzer-Holzer.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ATLANTA, May 01, 2023 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC informs investors that it has filed a class action lawsuit against Fulcrum Therapeutics, Inc. (\u201cFulcrum\u201d\u202for the \u201cCompany\u201d) (NASDAQ: FULC). The lawsuit alleges Fulcrum made materially false and\/or misleading statements and\/or failed to disclose material adverse facts about the Company\u2019s business, operations, and compliance policies, including: (i) the preclinical data submitted in support of the Company\u2019s drug candidate, FTX-6058, showed safety concerns regarding potential hematological malignancies; (ii) the foregoing safety concerns increased the likelihood that the FDA would place a clinical hold on preclinical studies of FTX-6058; and (iii) accordingly, the Company had overstated FTX-6058\u2019s clinical and\/or commercial prospects. If you bought shares of Fulcrum between March 3, 2022 and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Fulcrum Therapeutics, Inc. (FULC) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors &#8211; Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-753127","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Fulcrum Therapeutics, Inc. (FULC) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors - Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fulcrum Therapeutics, Inc. (FULC) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors - Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ATLANTA, May 01, 2023 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC informs investors that it has filed a class action lawsuit against Fulcrum Therapeutics, Inc. (\u201cFulcrum\u201d\u202for the \u201cCompany\u201d) (NASDAQ: FULC). The lawsuit alleges Fulcrum made materially false and\/or misleading statements and\/or failed to disclose material adverse facts about the Company\u2019s business, operations, and compliance policies, including: (i) the preclinical data submitted in support of the Company\u2019s drug candidate, FTX-6058, showed safety concerns regarding potential hematological malignancies; (ii) the foregoing safety concerns increased the likelihood that the FDA would place a clinical hold on preclinical studies of FTX-6058; and (iii) accordingly, the Company had overstated FTX-6058\u2019s clinical and\/or commercial prospects. If you bought shares of Fulcrum between March 3, 2022 and &hellip; Continue reading &quot;Fulcrum Therapeutics, Inc. (FULC) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors &#8211; Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-01T15:10:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTA4NyM1NTY3MTk5IzIxODA3Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Fulcrum Therapeutics, Inc. (FULC) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors &#8211; Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm\",\"datePublished\":\"2023-05-01T15:10:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\\\/\"},\"wordCount\":340,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTA4NyM1NTY3MTk5IzIxODA3Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\\\/\",\"name\":\"Fulcrum Therapeutics, Inc. (FULC) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors - Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTA4NyM1NTY3MTk5IzIxODA3Njc=\",\"datePublished\":\"2023-05-01T15:10:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTA4NyM1NTY3MTk5IzIxODA3Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyOTA4NyM1NTY3MTk5IzIxODA3Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fulcrum Therapeutics, Inc. (FULC) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors &#8211; Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fulcrum Therapeutics, Inc. (FULC) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors - Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\/","og_locale":"en_US","og_type":"article","og_title":"Fulcrum Therapeutics, Inc. (FULC) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors - Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm - Market Newsdesk","og_description":"ATLANTA, May 01, 2023 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC informs investors that it has filed a class action lawsuit against Fulcrum Therapeutics, Inc. (\u201cFulcrum\u201d\u202for the \u201cCompany\u201d) (NASDAQ: FULC). The lawsuit alleges Fulcrum made materially false and\/or misleading statements and\/or failed to disclose material adverse facts about the Company\u2019s business, operations, and compliance policies, including: (i) the preclinical data submitted in support of the Company\u2019s drug candidate, FTX-6058, showed safety concerns regarding potential hematological malignancies; (ii) the foregoing safety concerns increased the likelihood that the FDA would place a clinical hold on preclinical studies of FTX-6058; and (iii) accordingly, the Company had overstated FTX-6058\u2019s clinical and\/or commercial prospects. If you bought shares of Fulcrum between March 3, 2022 and &hellip; Continue reading \"Fulcrum Therapeutics, Inc. (FULC) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors &#8211; Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-01T15:10:11+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTA4NyM1NTY3MTk5IzIxODA3Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Fulcrum Therapeutics, Inc. (FULC) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors &#8211; Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm","datePublished":"2023-05-01T15:10:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\/"},"wordCount":340,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTA4NyM1NTY3MTk5IzIxODA3Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\/","name":"Fulcrum Therapeutics, Inc. (FULC) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors - Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTA4NyM1NTY3MTk5IzIxODA3Njc=","datePublished":"2023-05-01T15:10:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTA4NyM1NTY3MTk5IzIxODA3Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyOTA4NyM1NTY3MTk5IzIxODA3Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fulcrum-therapeutics-inc-fulc-class-action-lawsuit-filed-by-holzer-holzer-llc-on-behalf-of-investors-nationally-ranked-investors-rights-firm-encourages-investors-with-significant\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Fulcrum Therapeutics, Inc. (FULC) Class Action Lawsuit Filed by Holzer &amp; Holzer, LLC on Behalf of Investors &#8211; Nationally Ranked Investors\u2019 Rights Firm Encourages Investors With Significant Losses to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/753127","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=753127"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/753127\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=753127"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=753127"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=753127"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}